| Trial ID: | L0289 |
| Source ID: | NCT00267670
|
| Associated Drug: |
Pentoxifylline
|
| Title: |
Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
Has Results
|
| Results: |
https://ClinicalTrials.gov/show/NCT00267670/results
|
| Conditions: |
Nonalcoholic Steatohepatitis|Liver Diseases
|
| Interventions: |
Drug: Pentoxifylline|Drug: Placebo
|
| Outcome Measures: |
The Number of Participants With a 30% Reduction in Alanine Aminotransferase (ALT) Treated With Pentoxifylline (PTX) or Placebo for 12 Months.|The Effect of Pentoxifylline on Change in Tumor Necrosis Factor [TNF]-?? Levels in Patients With NASH|Change in Serum Leptin Levels in Patients Treated With Pentoxifylline or Placebo for 12 Months|Change in Serum Adiponectin Levels in Patients Treated With Pentoxifylline or Placebo for 12 Months
|
| Sponsor/Collaborators: |
Northwestern University
|
| Gender: |
All
|
| Age: |
18 Years to 65 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 2/Phase 3
|
| Enrollment: |
26
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment
|
| Start Date: |
March 2005
|
| Completion Date: |
September 2009
|
| Results First Posted: |
September 9, 2014
|
| Last Update Posted: |
September 9, 2014
|
| Locations: |
Northwestern University, Chicago, Illinois, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT00267670
|
